BioHarvest Sciences (BHST) FY Conference August 12, 2025 11:00 AM ET Speaker0I can go ahead and should we go ahead? Okay. Thank you everyone for attending our conference today. I'm Susan Anderson, one of Canaccord's analysts in the consumer space. And we're very excited to have here BioHarvest and in particular to host CEO, Ilan Sibel.Ilan, I'll turn it over to you to tell us more about the BioHarvest and the amazing products.Speaker1Thank you, Susan. Wow. Oh, they started the clock already. Jeez. Okay.I th ...

BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -36.36%. A quarter ago, it was expected that this company would post a loss of $0.15 per share when it actually produced a loss of $0.13, delivering a surprise of +13.33%.Over the last four quarters, the company ...

Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content delivered by the team includes insights across various sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans to maintain quality and best practices in content production [5]

BioHarvest Sciences (BHST) Q2 2025 Earnings Call August 11, 2025 08:00 AM ET Speaker0Greetings, and welcome to the BioHarvest Sciences Second Quarter twenty twenty five Corporate Update Conference Call. At this time, all participants are in listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. Before we begin the formal presentation, I'd like to remind everyone that statements made on today's call and webcast, including those r ...

Group 1 - BioHarvest Sciences Inc. (BHST) shares increased by 5.6% to close at $7.29, supported by higher trading volume compared to normal sessions [1] - The company's proprietary technology platform for growing plant-based molecules without the need for the underlying plant has generated positive investor sentiment [1] - The stock has shown a 0.1% gain over the past four weeks, indicating a recent upward trend [1] Group 2 - The company is expected to report a quarterly loss of $0.11 per share, reflecting a year-over-year change of -175%, while revenues are projected to be $8.77 million, up 45.4% from the previous year [2] - The consensus EPS estimate for BioHarvest has remained unchanged over the last 30 days, suggesting that stock price movements may not continue without earnings estimate revisions [3] - BioHarvest Sciences Inc. holds a Zacks Rank of 3 (Hold), indicating a neutral outlook compared to other stocks in the Zacks Medical - Biomedical and Genetics industry [4] Group 3 - Ultragenyx, another company in the same industry, closed 5.9% higher at $28.01, but has seen a -28.9% return over the past month [4] - Ultragenyx's consensus EPS estimate has changed by -1.8% over the past month to -$1.28, which is a +15.8% change from the previous year [5] - Ultragenyx currently has a Zacks Rank of 4 (Sell), indicating a less favorable outlook compared to BioHarvest [5]

Core Insights - BioHarvest Sciences Inc. has been invited to present at the Canaccord Genuity 45th Annual Growth Conference scheduled for August 12-14, 2025, in Boston, Massachusetts [1] - CEO Ilan Sobel will conduct one-on-one meetings with institutional investors and will present the company's growth plans during the conference [2][3] - The company is focused on building momentum in both its consumer and contract development and manufacturing organization (CDMO) businesses, aiming to scale operations effectively [3] Company Overview - BioHarvest Sciences Inc. specializes in Botanical Synthesis, utilizing its patented technology to produce plant-based compounds without the need for growing the actual plants [4] - The company operates in two main business verticals: as a CDMO for clients seeking novel plant-based compounds and as a creator of proprietary nutraceutical health and wellness products, including dietary supplements [4]

Core Insights - BioHarvest Sciences Inc. has launched a new product in its Vinia line, a daily "2X formula" chew designed for athletes and active consumers, delivering 12mg of Piceid Resveratrol, which is double the amount found in the original capsule format [1][5]. Product Development - The new chew was developed based on insights gained from working with athletes during the NFL combine, indicating that a higher dosage was necessary for noticeable effects [5]. - The chew is designed to be convenient, great tasting, and low in calories, containing only 15 calories per chew [6]. Market Positioning - The product is certified by Informed Sport, which is crucial for athletes concerned about anti-doping standards, thus expanding its market appeal to both amateur and professional athletes [6][7]. - This certification opens new distribution channels and is expected to drive incremental revenue and customer acquisition for the Vinia brand [8]. Future Strategy - The company plans to continue expanding its product line with a "Vinia inside" strategy, focusing on superior science and efficacy, and has plans to launch a new product targeting the US$16 billion US hydration market within the next 120 days [9][10].

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive has bureaus and studios in key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2][3] Group 2 - The company is focused on sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] - Proactive adopts technology to enhance workflows and improve content production [4] - Automation and software tools, including generative AI, are used, but all content is edited and authored by humans [5]

Core Viewpoint - BioHarvest Sciences Inc. has launched VINIA® DailyChews 2X Formula, a chewable product designed to enhance nitric oxide production and improve blood flow for athletes and active individuals, now available for purchase online [1][3]. Product Details - VINIA® DailyChews 2X Formula contains 800mg of VINIA® and 12mg of Piceid resveratrol, which is clinically shown to increase arterial dilation, thereby improving physical energy and mental alertness [3]. - The product is Informed Sport-certified, ensuring that every batch is tested for banned substances, making it suitable for professional athletes and fitness enthusiasts [2][3]. Market Strategy - The launch targets the multi-billion-dollar nutraceuticals market, aiming to attract a younger consumer base and expand into the athlete and fitness enthusiast segment [3]. - BioHarvest is enhancing its international e-commerce platform to facilitate global orders, allowing customers in countries like the UK and Australia to receive products directly [3]. Company Background - BioHarvest Sciences Inc. specializes in Botanical Synthesis technology, enabling the growth of plant-based compounds without the need for the actual plants [8]. - The company operates in two major business verticals: as a contract development and manufacturing organization (CDMO) and as a creator of proprietary nutraceutical health and wellness products [8].

Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for successful short-term investing, highlighting that price movements should be supported by strong fundamentals and positive earnings estimates [1][2]. Group 1: Stock Performance - BioHarvest Sciences Inc. (BHST) has shown a solid price increase of 26.6% over the past 12 weeks, indicating investor confidence in its potential upside [4]. - The stock has also increased by 6% over the past four weeks, suggesting that the upward trend is still intact [5]. - BHST is currently trading at 93.6% of its 52-week high-low range, indicating a potential breakout [5]. Group 2: Fundamental Strength - BHST holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7]. Group 3: Investment Strategy - The article suggests using the "Recent Price Strength" screen to identify stocks like BHST that are on an uptrend supported by strong fundamentals [3]. - It also mentions that there are over 45 Zacks Premium Screens available for investors to find stocks that fit their personal investing styles [8].